Covid-19: UK signs up for Sanofi-GSK vaccine
PARIS, July 29 (NNN-AGENCIES) — Pharma giants Sanofi and GSK have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine, the firms announced Wednesday.
The agreement covers a vaccine candidate developed by France’s Sanofi in partnership with the UK’s GSK and is subject to a “final contract”.
Amid a global race to find a vaccine to halt the pandemic, Sanofi announced “Ongoing discussions with the European Commission, with France and Italy on the negotiation team, and other governments to ensure global access to a novel coronavirus vaccine.”
- Read more about Covid-19: UK signs up for Sanofi-GSK vaccine
- Log in or register to post comments